Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0SSOGE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-CD22 antibody drug-conjugate (Medarex/BMS)
|
|||||
| Synonyms |
Anti-CD22 antibody drug-conjugates (Medarex/BMS)
Click to Show/Hide
|
|||||
| Organization |
Medarex, Inc.; Bristol Myers Squibb Co.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
B-cell lymphoma [ICD11:2A86]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.